...
首页> 外文期刊>Applied radiology >Hepatic-portal interventions
【24h】

Hepatic-portal interventions

机译:肝门干预

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Major advances in the percutaneous management of hepatoportal venous disease and portal hypertension have been introduced in the past decade. These include catheter-directed thrombolysis, mechanical thrombectomy, embolization, recanalization, balloon angioplasty (percutaneous transluminal angioplasty (PTA)), stent placement, and transjugular intrahepatic portosystemic shunt (TIPS). TIPS has proved to be a safe and effective interventional radiological procedure for the treatment of acute variceal hemorrhage that is unresponsive to sclerotherapy, intractable ascites, and Budd-Chiari syndrome. In addition, it has largely replaced surgical shunt procedures. Recanalization and stenting can relieve hepatic outflow obstruction effectively in patients with Budd-Chiari syndrome. The transhepatic or transjugular approach allows for a variety of percutaneous radiologic interventions for occlusive portal vein diseases, including acute and chronic portal vein thrombosis and portal vein stenosis. The interventionalradiologist has played a major role in developing and advancing techniques that have the potential to replace many of the traditional medical and surgical treatments for a variety of occlusive disorders in the hepatic and portal veins and inferior vena cava.
机译:在过去的十年中,在经皮处理肝门静脉疾病和门脉高压症方面取得了重大进展。这些包括导管定向溶栓,机械血栓切除术,栓塞,再通,球囊血管成形术(经皮腔内血管成形术(PTA)),支架置入和经颈静脉肝内门体分流术(TIPS)。 TIPS已被证明是对硬化疗法,顽固性腹水和Budd-Chiari综合征无反应的急性静脉曲张破裂出血的治疗的安全有效的介入放射学程序。此外,它已大大取代了外科分流手术。再通和支架置入术可有效缓解Budd-Chiari综合征患者的肝外流阻塞。经肝或经颈静脉途径允许对闭塞性门静脉疾病进行多种经皮放射学干预,包括急性和慢性门静脉血栓形成和门静脉狭窄。介入放射科医师在开发和发展技术方面发挥了重要作用,这些技术有可能取代许多传统的医学和外科治疗方法,以治疗肝,门静脉和下腔静脉的各种闭塞性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号